Strong first year as standalone company; global leader Sandoz uniquely positioned in attractive and growing USD 200 billion market for generics and biosimilars Leading in home market Europe ...

Intra-Cellular Therapies, Inc. announced a settlement with Sandoz Inc. regarding patent litigation involving their product CAPLYTA® (lumateperone). This litigation arose from Sandoz's attempt to ...

“Part of the trip was exhilarating,” Gates admits — but it was less fun the following day, when he was still “feeling its effects” during dental surgery Maria Pasquini is the staff ...

After months of deliberation, and no formal offers from a buyer, Novartis has decided that its generics business Sandoz will be spun out into an independent company. The Swiss pharma group said ...

Generic and biosimilar drug producer Sandoz has agreed a $265 million settlement that aims to put allegations of price-fixing brought in a Pennsylvania lawsuit behind it. The agreement – which ...

In his memoir Source Code, Microsoft founder Bill Gates revealed that he tried drugs to impress girls, but the experience with LSD scared him and he never did it again.(Reuters / Andrew Kelly ...

LSD is a powerful illegal psychedelic drug with the potential for serious mental and physical harm. That didn’t stop the CIA from testing it on unsuspecting people, some of whom developed long ...

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...